Toggle Main Menu Toggle Search

ePrints

Browsing publications by Dr Neil Rajan

Newcastle AuthorsTitleYearFull text
Dr Sara Brown
Dr Jannath Ahmed
Dr Simon Zwolinski
Dr Paul Brennan
Dr Neil Rajan
et al.
A novel link between keratoderma and cardiomyopathy: Contiguous gene deletion involving the desmoglein gene cluster2018
Dr Sarah Brown
Dr Majid Arefi
Robert Stones
Dr James Langtry
Dr Sylvia Worthy
et al.
Inherited pulmonary cylindromas: Extending the phenotype of CYLD mutation carriers2018
Dr Dalvir Bajwa
Dr Batoul Nasr
Dr Neil Rajan
Milia: a useful clinical marker of CYLD mutation carrier status2018
Dr Ruairidh Martin
Dr Majid Arefi
Dr Miranda Splitt
Lisa Redford
Dr Neil Rajan
et al.
Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation2018
Dr Marina Danilenko
Elaine Stamp
Dr Deborah Stocken
Monique Zangarini
Amy Cranston
et al.
Targeting tropomyosin receptor kinase in cutaneous CYLD defective tumors (TRAC): A randomised placebo-controlled early phase trial with pegcantratinib2018
Dr Sylvia Worthy
Dr James Langtry
Dr Neil Rajan
Tracking tumor kinetics in patients with germline CYLD mutations2018
Dr Marina Danilenko
Robert Stones
Dr Neil Rajan
Transcriptomic profiling of human skin biopsies in the clinical trial setting: A protocol for high quality RNA extraction from skin tumours2018
Monique Zangarini
Dr Neil Rajan
Dr Marina Danilenko
Philip Berry
Dr Gareth Veal
et al.
Development and validation of LC–MS/MS with in-source collision-induced dissociation for the quantification of pegcantratinib in human skin tumors2017
Amy Cranston
Dr Deborah Stocken
Elaine Stamp
Professor Ruth Plummer
Professor Sir John Burn
et al.
Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial.2017
Kirsty Hodgson
Dr Neil Rajan
Understanding Inherited Cylindromas Clinical Implications of Gene Discovery2017
123456